首页> 外文期刊>Toxicology Letters: An International Journal Providing a Forum for Original and Pertinent Contributions in Toxicology Research >A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity
【24h】

A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity

机译:通过长时间的超级计算机分子动力学模拟生成的人类醚相关(hERG)离子通道原子模型及其在预测药物心脏毒性中的用途

获取原文
获取原文并翻译 | 示例
           

摘要

Acquired cardiac long QT syndrome (LQTS) is a frequent drug-induced toxic event that is often caused through blocking of the human ether-á-go-go-related (hERG) K+ ion channel. This has led to the removal of several major drugs post-approval and is a frequent cause of termination of clinical trials. We report here a computational atomistic model derived using long molecular dynamics that allows sensitive prediction of hERG blockage. It identified drug-mediated hERG blocking activity of a test panel of 18 compounds with high sensitivity and specificity and was experimentally validated using hERG binding assays and patch clamp electrophysiological assays. The model discriminates between potent, weak, and non-hERG blockers and is superior to previous computational methods. This computational model serves as a powerful new tool to predict hERG blocking thus rendering drug development safer and more efficient. As an example, we show that a drug that was halted recently in clinical development because of severe cardiotoxicity is a potent inhibitor of hERG in two different biological assays which could have been predicted using our new computational model.
机译:获得性心脏长QT综合征(LQTS)是一种常见的药物诱发的中毒事件,通常是由于人与人走动相关(hERG)的K +离子通道受阻引起的。这导致批准后撤消了几种主要药物,并且是终止临床试验的常见原因。我们在这里报告使用长分子动力学推导的计算原子模型,该模型允许对hERG阻滞进行敏感预测。它鉴定了由18种化合物组成的测试小组的药物介导的hERG阻断活性,具有高灵敏度和特异性,并使用hERG结合测定法和膜片钳电生理测定法进行了实验验证。该模型可区分有效,弱和非hERG阻滞剂,并且优于先前的计算方法。该计算模型可作为预测hERG阻断的强大新工具,从而使药物开发更安全,更有效。例如,我们表明,由于严重的心脏毒性,最近在临床开发中停止使用的药物在两种不同的生物学测定中是hERG的有效抑制剂,这可以使用我们的新计算模型进行预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号